Latest filing published 16 Jan 2018 for MABVAX THERAPEUTICS HOLDINGS, INC..
Filing timeline
BuySaleInsider track record
Philip O. Livingston: trading record in brief
This profile gathers the share dealings of Philip O. Livingston in Mabvax Therapeutics Holdings, Inc. In total, 5 filings cover trades dated from 4 April 2015 to 12 January 2018.
Every open-market trade on record is a sale: 3 sales worth €30k. Other entries cover 1 share grant and 1 option exercise. So far in 2018, the count stands at no purchases and 3 sales.
On 16 January 2018 came the latest disclosure, an option exercise in Mabvax Therapeutics Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Philip O. Livingston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares0Common StockSEC:0001415889-18-000061:0
- 21,155 shares@ US$0.9656.8% of flowCommon StockSEC:0001415889-18-000061:1
- 12,301 shares@ US$0.9833.7% of flowCommon StockSEC:0001415889-18-000061:2
- 3,571 shares@ US$0.969.5% of flowCommon StockSEC:0001415889-18-000061:3
- 1,000,000 shares0Common StockSEC:0001209191-15-032973:0
5 of 5 declarations